Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2024 Results Conference Call August 7, 2024 5:00 PM ET

Company Participants

Deborah Hart - Head, Investor Relations
Trey Martin - Chief Executive Officer
Kevin Herde - Chief Financial Officer
Drew Burch - President, Nucleic Acid Production
Becky Buzzeo - Chief Commercial Officer

Conference Call Participants

Catherine Schulte - Baird
Tejas Savant - Morgan Stanley
Matt Hewitt - Craig-Hallum
Justin Bowers - Deutsche Bank
Conor McNamara - RBC Capital Markets
Michael Ryskin - Bank of America
Matt Larew - William Blair
Kyle Crews - UBS

Operator

Thank you for standing by and welcome to the Maravai LifeSciences Second Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions]

I'd now like to turn the call over to Deborah Hart, Head of Investor Relations. You may begin.

Deborah Hart

Good afternoon, everyone. Thanks for joining us on our second quarter 2024 earnings call. Our press release and the slides accompanying today's call are posted on our website and available at investors.maravai.com.

As you can see on our agenda for today on Slide 2, Trey will first provide you with a business update; and Kevin will review our financial results and guidance. Drew Burch, President of Nucleic Acid Production; and Becky Buzzeo, our Chief Commercial Officer, will join the call for the question-and-answer session following the prepared remarks.

During today’s call, management will make forward-looking statements. It is possible that actual results could differ from management's expectations. We refer you to Slide 3 for more detail on forward-looking statements. Also, during this call, we will be referring to certain financial measures not prepared in accordance with generally accepted accounting principles or GAAP.

A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures is available in the press release and also posted to the investor section of our website. Please also refer to Maravai SEC filings for additional information on the risks and uncertainties that may impact our operating results, performance and financial condition.

Now, I'll turn the call over to Trey.

Trey Martin

Thank you, Deb, and good afternoon, everyone. We appreciate you joining us for our call today. Let me briefly recap the quarter, share an update on our new Flanders facilities, highlight some innovative new products we introduced, and provide a few additional business updates before turning the call over to Kevin.